Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/178242
Title: | Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018) |
Author: | Darbà, Josep Marsà, Alícia |
Keywords: | Cost de l'assistència sanitària Gestió hospitalària Hepatitis Malalties del fetge Cost of medical care Hospital administration Hepatitis Liver diseases |
Issue Date: | 4-May-2021 |
Publisher: | Informa Healthcare |
Abstract: | Intrahepatic cholangiocarcinomas (iCCA) are aggressive tumors, often diagnosed in advanced stages and with limited curative treatment options. Their incidence has raised in the past years, increasing their associated economic burden. This study aimed to measure hospital incidence and mortality of iCCA and to evaluate direct medical costs. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1842201 |
It is part of: | Expert Review of Pharmacoeconomics & Outcomes Research, 2021, vol. 21, núm. 3, p. 425-431 |
URI: | http://hdl.handle.net/2445/178242 |
Related resource: | https://doi.org/10.1080/14737167.2021.1842201 |
ISSN: | 1473-7167 |
Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
703978.pdf | 493.01 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.